- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06514170
Gastrointestinal Dysfunction in Aortic Surgery Patients
July 23, 2024 updated by: Gustavo Rojas Velasco, Instituto Nacional de Cardiologia Ignacio Chavez
Assessment of Gastrointestinal Dysfunction Through GIDS Scale and Intestinal Damage Biomarkers in Critically Ill Patients Undergoing Aortic Surgery and Its Association With Clinical Outcomes.
The goal of this observational study is to determine the association of gastrointestinal dysfunction through the Gastrointestinal Dysfunction Scale (GIDS) tool and serum concentrations of citrulline and Intestinal fatty-acid binding protein (I-FABP) with primary [calories received, protein received, parenteral nutrition requirement and 28-day mortality in the intensive care unit (ICU)] and secondary (development of pneumonia, surgical and cardiovascular complications in the ICU, length of hospital and ICU stay, duration of mechanical ventilation) clinical outcomes in critically ill patients undergoing aortic surgery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The treatment of choice for various cardiovascular diseases often involves cardiac surgery, including aortic surgery, which is performed to correct conditions related to this major vessel, such as aneurysms, stenosis, aortic dissections, as well as issues affecting the aortic valve.
With the increasing prevalence of non-communicable chronic diseases, a 46% increase in demand for cardiac surgeries is projected by 2025.
The post-surgical period, commonly in the intensive care unit (ICU), increases the risk of complications, especially in patients with pre-existing risk factors.
In this regard, gastrointestinal (GI) dysfunction affects up to 63% of patients, being associated with complications and a mortality rate of 55% to 60%.
Early detection of GI dysfunction allows for the implementation of management strategies.
Additionally, the administration of appropriate nutritional therapy is essential for recovery, and GI dysfunction may limit nutrient absorption.
Inadequate caloric intake has been linked to increased morbidity and mortality.
Tools such as GIDS (Gastrointestinal Dysfunction Scale) and biomarkers like citrulline and I-FABP enable early evaluation of GI function, advancing monitoring and management.
Identifying changes before serious complications arise allows for early and personalized interventions.
Early detection not only prevents complications and improves quality of life but may also reduce mortality.
This research project aims to address these gaps by early assessing GI dysfunction in post-aortic surgery patients.
Utilizing the GIDS tool and biomarkers such as citrulline and I-FABP, the goal is to identify GI dysfunction early and its impact on nutrition administration.
Study Type
Observational
Enrollment (Estimated)
114
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gustavo Rojas Velasco, MD
- Phone Number: 24507 +52 55 55732911
- Email: gustavorojas08@gmail.com
Study Contact Backup
- Name: Jacob J Cruz Sánchez, MSc.
- Phone Number: +52 5512439841
- Email: jacob.cruz@cardiologia.org.mx
Study Locations
-
-
Tlalpan
-
Ciudad de mexico, Tlalpan, Mexico, 14080
- Recruiting
- Instituto Nacional de Cardiologia Ignacio Chavez
-
Contact:
- Gustavo Rojas Velasco, MD
- Phone Number: 24507 +52 55 55732911
- Email: gustavorojas08@gmail.com
-
Contact:
- Jacob J Cruz Sánchez, MSc
- Phone Number: +52 5512439841
- Email: jacob.cruz@cardiologia.org.mx
-
Sub-Investigator:
- Jacob J Cruz Sánchez, MSc
-
Sub-Investigator:
- Daniel Manzur Sandoval, MD
-
Sub-Investigator:
- Carla G Aguilar Rodríguez, MD
-
Sub-Investigator:
- Eduardo A Escudero González, MD
-
Sub-Investigator:
- María L Tovar Hernández, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Adult patients following aortic surgery necessitating invasive mechanical ventilation and an intensive care unit stay of ≥ 48 hours.
Description
Inclusion Criteria:
- 18 years of age or older.
- Patients after surgical interventions (elective or urgency) on the aorta with cardiopulmonary bypass.
- Invasive mechanical ventilation expected to be required more than 48 hours.
- Signed informed consent.
Exclusion Criteria:
- Patients under mechanical ventilation with pre-existing gastrointestinal issues.
- Diagnosis of adult congenital heart disease.
- Ongoing pregnancy or lactation period.
- Simultaneous participation in another clinical study involving experimental therapy.
- Presence of chronic intestinal disease.
- Previous gastrointestinal conditions detected during nutritional screening.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calories delivered daily enterally and/or parenterally
Time Frame: Day 0 to day 7
|
Percentage representation of prescribed calories delivered daily via enteral and/or parenteral routes.
|
Day 0 to day 7
|
|
Protein delivered daily enterally and/or parenterally
Time Frame: Day 0 to day 7
|
Daily administration of protein (in grams) through enteral and/or parenteral routes.
|
Day 0 to day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence rate of hospital-acquired infections
Time Frame: 7 days
|
Infections acquired in the hospital consist of ventilator-associated pneumonia, bloodstream infections, and infections related to urinary catheters
|
7 days
|
|
Percentage of repeated operations
Time Frame: 90 days
|
This outcome measures the percentage of patients who undergo one or more additional surgical operations related to the same condition after the initial surgery.
The percentage is calculated by dividing the number of patients who require a repeat operation by the total number of patients who underwent the initial operation, multiplied by 100 to get the percentage.
|
90 days
|
|
ICU readmission rate
Time Frame: 90 days
|
Occurrences of patients being readmitted to the ICU from within the hospital.
|
90 days
|
|
ICU length of stay
Time Frame: 90 days
|
Duration of time (days) in the ICU
|
90 days
|
|
Duration of mechanical ventilation
Time Frame: 90 days
|
Length of time (days) on mechanical ventilation (including still on mechanical ventilation at time of discharge)
|
90 days
|
|
Hospital length of stay
Time Frame: 90 days
|
Duration of time (days) in the hospital
|
90 days
|
|
Parenteral nutrition requirement
Time Frame: Day 0 to day 7
|
Parenteral nutrition requirement
|
Day 0 to day 7
|
|
28-day mortality in the ICU
Time Frame: 28 days
|
Is the patient alive or deceased 28 days post admission.
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gustavo Rojas Velasco, MD, Head of the Cardiovascular Intensive Care Unit
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Reintam Blaser A, Padar M, Mandul M, Elke G, Engel C, Fischer K, Giabicani M, Gold T, Hess B, Hiesmayr M, Jakob SM, Loudet CI, Meesters DM, Mongkolpun W, Paugam-Burtz C, Poeze M, Preiser JC, Renberg M, Rooijackers O, Tamme K, Wernerman J, Starkopf J. Development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients - A prospective multicenter observational study (iSOFA study). Clin Nutr. 2021 Aug;40(8):4932-4940. doi: 10.1016/j.clnu.2021.07.015. Epub 2021 Jul 18.
- Stoppe C, Spillner J, Rossaint R, Coburn M, Schalte G, Wildenhues A, Marx G, Rex S. Selenium blood concentrations in patients undergoing elective cardiac surgery and receiving perioperative sodium selenite. Nutrition. 2013 Jan;29(1):158-65. doi: 10.1016/j.nut.2012.05.013. Epub 2012 Sep 23.
- Reintam Blaser A, Preiser JC, Fruhwald S, Wilmer A, Wernerman J, Benstoem C, Casaer MP, Starkopf J, van Zanten A, Rooyackers O, Jakob SM, Loudet CI, Bear DE, Elke G, Kott M, Lautenschlager I, Schaper J, Gunst J, Stoppe C, Nobile L, Fuhrmann V, Berger MM, Oudemans-van Straaten HM, Arabi YM, Deane AM; Working Group on Gastrointestinal Function within the Section of Metabolism, Endocrinology and Nutrition (MEN Section) of ESICM. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care. 2020 May 15;24(1):224. doi: 10.1186/s13054-020-02889-4.
- van Zanten AR. Nutrition barriers in abdominal aortic surgery: a multimodal approach for gastrointestinal dysfunction. JPEN J Parenter Enteral Nutr. 2013 Mar;37(2):172-7. doi: 10.1177/0148607112464499. Epub 2012 Oct 24. No abstract available.
- Liu X, Wang Q, Yang D, Fu M, Yang M, Bi Y, Wang C, Song X. Association between Gastrointestinal Dysfunction Score (GIDS) and disease severity and prognosis in critically ill patients: A prospective, observational study. Clin Nutr. 2023 May;42(5):700-705. doi: 10.1016/j.clnu.2023.03.004. Epub 2023 Mar 7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 23, 2024
Primary Completion (Estimated)
April 1, 2026
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
July 9, 2024
First Submitted That Met QC Criteria
July 16, 2024
First Posted (Actual)
July 23, 2024
Study Record Updates
Last Update Posted (Actual)
July 24, 2024
Last Update Submitted That Met QC Criteria
July 23, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24-1427
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Dysfunction
-
Coconut Goodness Food Products Inc.Active, not recruitingGastrointestinal DysfunctionUnited States
-
James J. Peters Veterans Affairs Medical CenterWithdrawnGastrointestinal DysfunctionUnited States
-
Zhenyu ZhangGuangzhou University of Chinese MedicineEnrolling by invitationGastrointestinal DysfunctionChina
-
University Hospitals of North Midlands NHS TrustCompleted
-
Colorado State UniversityArcher Daniels Midland CompanyCompletedGastrointestinal DysfunctionUnited States
-
Tianjin Nankai HospitalUnknownGastrointestinal Dysfunction
-
The Archer-Daniels-Midland CompanyMerieux NutriSciences (China)Not yet recruitingGastrointestinal Dysfunction
-
RDC Clinical Pty LtdMaolacCompleted
-
University of NottinghamCompletedGastrointestinal DysfunctionUnited Kingdom
-
Istanbul Medeniyet UniversityCompleted
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted